6861:TSEKeyence Corporation Analysis
Data as of 2026-07-03 - not real-time
¥80,300.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Keyence Corp (6861.T) is trading at ¥80,300, comfortably above its 20‑day (¥76,749) and 200‑day (¥62,451) simple moving averages, confirming a strong bullish bias. The MACD line sits at ¥1,390 above its signal (¥1,038) and the histogram remains positive, while the RSI of 59 indicates momentum still in the upside territory. Revenue is expanding at a robust 17.9% YoY, delivering industry‑leading gross (83%) and operating (53.6%) margins, and the company generates ample free cash flow with zero debt and a cash pile exceeding ¥1.4 trillion. However, the market price implies a forward P/E of 43.8, well above the industry average of 36, and the DCF‑derived fair value of ¥41,229 is less than half the current price, suggesting the stock is considerably overvalued. The modest dividend yield of 0.68% with a 30% payout ratio is sustainable given the strong earnings and cash generation. Volatility is elevated at 36.6% over the past 30 days, yet the beta of 0.61 points to lower systematic risk, and the Fear & Greed Index sits at an extreme‑greed 92.98, hinting at possible sentiment‑driven price pressure.
Analyst consensus remains “Buy” with a median target of ¥86,700, implying limited upside (~5‑8%) and a modest downside cushion. The technical picture is bullish but volume trends are weakening, and the overvaluation gap means price appreciation will likely be incremental and tied to continued earnings growth. Given the solid fundamentals, low leverage, and global customer base, the investment case remains attractive for medium‑ to long‑term horizons, while short‑term traders should be cautious of the high volatility and sentiment‑driven environment.
Analyst consensus remains “Buy” with a median target of ¥86,700, implying limited upside (~5‑8%) and a modest downside cushion. The technical picture is bullish but volume trends are weakening, and the overvaluation gap means price appreciation will likely be incremental and tied to continued earnings growth. Given the solid fundamentals, low leverage, and global customer base, the investment case remains attractive for medium‑ to long‑term horizons, while short‑term traders should be cautious of the high volatility and sentiment‑driven environment.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near resistance at ¥82,400
- Decreasing volume trend
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained earnings growth and high margins
- Strong cash generation and zero debt
- Analyst consensus and target price upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust revenue expansion and market leadership in sensors
- Low beta indicating defensive characteristics
- Dividend sustainability and solid balance sheet
Key Metrics & Analysis
Financial Health
Revenue Growth17.90%
Profit Margin38.07%
P/E Ratio43.8
ROE13.53%
ROA10.70%
P/B Ratio5.6
Op. Cash Flow¥430.7B
Free Cash Flow¥308.7B
Industry P/E36.0
Technical Analysis
TrendBullish
RSI59.3
Support¥69,000.00
Resistance¥82,400.00
MA 20¥76,749.00
MA 50¥76,155.40
MA 200¥62,450.55
MACDBullish
VolumeDecreasing
Fear & Greed Index92.98
Valuation
Fair Value¥41,229.42
Target Price¥85,043.75
Upside/Downside5.91%
GradeOvervalued
TypeGrowth
Dividend Yield0.68%
Risk Assessment
Beta0.61
Volatility36.62%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.